BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1148 related articles for article (PubMed ID: 23737396)

  • 21. Ovarian suppression for adjuvant treatment of hormone receptor-positive early breast cancer.
    Bui KT; Willson ML; Goel S; Beith J; Goodwin A
    Cochrane Database Syst Rev; 2020 Mar; 3(3):CD013538. PubMed ID: 32141074
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Schedules for home visits in the early postpartum period.
    Yonemoto N; Nagai S; Mori R
    Cochrane Database Syst Rev; 2021 Jul; 7(7):CD009326. PubMed ID: 34286512
    [TBL] [Abstract][Full Text] [Related]  

  • 23. High-dose chemotherapy and autologous bone marrow or stem cell transplantation versus conventional chemotherapy for women with early poor prognosis breast cancer.
    Farquhar C; Marjoribanks J; Lethaby A; Azhar M
    Cochrane Database Syst Rev; 2016 May; 2016(5):CD003139. PubMed ID: 27200512
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Preventive health care, 2001 update: screening mammography among women aged 40-49 years at average risk of breast cancer.
    Ringash J;
    CMAJ; 2001 Feb; 164(4):469-76. PubMed ID: 11233866
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Screening for gestational diabetes mellitus based on different risk profiles and settings for improving maternal and infant health.
    Tieu J; McPhee AJ; Crowther CA; Middleton P; Shepherd E
    Cochrane Database Syst Rev; 2017 Aug; 8(8):CD007222. PubMed ID: 28771289
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Taxane-containing regimens for metastatic breast cancer.
    Ghersi D; Willson ML; Chan MM; Simes J; Donoghue E; Wilcken N
    Cochrane Database Syst Rev; 2015 Jun; 2015(6):CD003366. PubMed ID: 26058962
    [TBL] [Abstract][Full Text] [Related]  

  • 27. All-cause mortality among breast cancer patients in a screening trial: support for breast cancer mortality as an end point.
    Tabar L; Duffy SW; Yen MF; Warwick J; Vitak B; Chen HH; Smith RA
    J Med Screen; 2002; 9(4):159-62. PubMed ID: 12518005
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effect of mammographic screening from age 40 years on breast cancer mortality in the UK Age trial at 17 years' follow-up: a randomised controlled trial.
    Moss SM; Wale C; Smith R; Evans A; Cuckle H; Duffy SW
    Lancet Oncol; 2015 Sep; 16(9):1123-1132. PubMed ID: 26206144
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Multiple-micronutrient supplementation for women during pregnancy.
    Keats EC; Haider BA; Tam E; Bhutta ZA
    Cochrane Database Syst Rev; 2019 Mar; 3(3):CD004905. PubMed ID: 30873598
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Bisphosphonates for breast cancer.
    Pavlakis N; Schmidt R; Stockler M
    Cochrane Database Syst Rev; 2005 Jul; (3):CD003474. PubMed ID: 16034900
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Early postnatal discharge from hospital for healthy mothers and term infants.
    Jones E; Stewart F; Taylor B; Davis PG; Brown SJ
    Cochrane Database Syst Rev; 2021 Jun; 6(6):CD002958. PubMed ID: 34100558
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Primary prophylactic colony-stimulating factors for the prevention of chemotherapy-induced febrile neutropenia in breast cancer patients.
    Renner P; Milazzo S; Liu JP; Zwahlen M; Birkmann J; Horneber M
    Cochrane Database Syst Rev; 2012 Oct; 10():CD007913. PubMed ID: 23076939
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Beta-blockers for suspected or diagnosed acute myocardial infarction.
    Safi S; Sethi NJ; Nielsen EE; Feinberg J; Jakobsen JC; Gluud C
    Cochrane Database Syst Rev; 2019 Dec; 12(12):CD012484. PubMed ID: 31845756
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Use of biochemical tests of placental function for improving pregnancy outcome.
    Heazell AE; Whitworth M; Duley L; Thornton JG
    Cochrane Database Syst Rev; 2015 Nov; 2015(11):CD011202. PubMed ID: 26602956
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Long-term effects of mammography screening: updated overview of the Swedish randomised trials.
    Nyström L; Andersson I; Bjurstam N; Frisell J; Nordenskjöld B; Rutqvist LE
    Lancet; 2002 Mar; 359(9310):909-19. PubMed ID: 11918907
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Axillary treatment for operable primary breast cancer.
    Bromham N; Schmidt-Hansen M; Astin M; Hasler E; Reed MW
    Cochrane Database Syst Rev; 2017 Jan; 1(1):CD004561. PubMed ID: 28052186
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Immediate versus deferred delivery of the preterm baby with suspected fetal compromise for improving outcomes.
    Stock SJ; Bricker L; Norman JE; West HM
    Cochrane Database Syst Rev; 2016 Jul; 7(7):CD008968. PubMed ID: 27404120
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Interleukin-6 blocking agents for treating COVID-19: a living systematic review.
    Ghosn L; Chaimani A; Evrenoglou T; Davidson M; Graña C; Schmucker C; Bollig C; Henschke N; Sguassero Y; Nejstgaard CH; Menon S; Nguyen TV; Ferrand G; Kapp P; Riveros C; Ávila C; Devane D; Meerpohl JJ; Rada G; Hróbjartsson A; Grasselli G; Tovey D; Ravaud P; Boutron I
    Cochrane Database Syst Rev; 2021 Mar; 3(3):CD013881. PubMed ID: 33734435
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effectiveness of mammography screening in reducing breast cancer mortality in women aged 39-49 years: a meta-analysis.
    Magnus MC; Ping M; Shen MM; Bourgeois J; Magnus JH
    J Womens Health (Larchmt); 2011 Jun; 20(6):845-52. PubMed ID: 21413892
    [TBL] [Abstract][Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 58.